<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04646486</url>
  </required_header>
  <id_info>
    <org_study_id>TEAMOBS Intervention</org_study_id>
    <nct_id>NCT04646486</nct_id>
  </id_info>
  <brief_title>Video Debriefing at the Delivery Ward</brief_title>
  <official_title>Video Debriefing at the Delivery Ward - Empowering Obstetric Teams to High Performance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Horsens Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postpartum hemorrhage continues to be the leading cause of maternal morbidity and mortality&#xD;
      worldwide. Successful management of postpartum hemorrhage requires not only administration of&#xD;
      the right medicine, but also a rapid and coordinated response from a multi-professional team.&#xD;
      A prerequisite for this is that the individuals are well trained, which the investigators&#xD;
      believe can be improved by video debriefing of real-life events.&#xD;
&#xD;
      The purpose of this study is to improve obstetric teams management of postpartum hemorrhage&#xD;
      using video recordings of real-life events in post event debriefings.&#xD;
&#xD;
      Cameras are placed in the ceiling of all delivery rooms to record obstetric teams' management&#xD;
      of postpartum hemorrhage. Video recording requires informed consent from all participants.&#xD;
      After an event, the team will review their own performance on video in a debriefing session&#xD;
      to improve future performance.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:&#xD;
&#xD;
      Video review was first introduced in healthcare in the 1980s to improve emergency teams'&#xD;
      management of critical situations by having them review their own performance on video in a&#xD;
      debriefing session. Video debriefing offers an opportunity to review the care delivered in&#xD;
      high-stake, high-risk, and time-critical situations. Video debriefing has been found to&#xD;
      improve the performance of neonatal resuscitation teams and trauma teams; however, video&#xD;
      debriefing has not generally been accepted in the delivery ward. A recent PhD project&#xD;
      developed a method for systematically filming obstetric emergencies, in two Danish hospitals,&#xD;
      where informed consent had been obtained from all participants. In addition, the project&#xD;
      developed a method for systematically assessing obstetric teams' clinical performance during&#xD;
      postpartum hemorrhage&#xD;
&#xD;
      The aim of the study is to examine the effect of real-life video debriefing on obstetric&#xD;
      teams' management of major postpartum hemorrhage.&#xD;
&#xD;
      Material and methods:&#xD;
&#xD;
      The study will be conducted at two Danish hospitals, Aarhus University Hospital (5,000&#xD;
      deliveries per year) and Horsens Regional Hospital (2,300 deliveries per year).&#xD;
&#xD;
      All delivery rooms have been equipped with an automatic recording system that enables filming&#xD;
      of all postpartum hemorrhage. Video recording requires informed consent from all&#xD;
      participants. Women expecting to deliver will be invited to provide informed consent for&#xD;
      video recording. If a woman declines the invitation, the cameras will be covered up according&#xD;
      to our protocol. If video recording occurs, all participants will be asked to give informed&#xD;
      consent again.&#xD;
&#xD;
      Video debriefing will be conducted by educated facilitators of debriefing. Debriefings will&#xD;
      follow a protocol and will focus on teams' clinical performance and non-technical skills. The&#xD;
      main focus of the debriefing protocol will be clinical debriefing with a main goal of&#xD;
      improving clinical performance and patient care.&#xD;
&#xD;
      Videos will be included as follows: 1) Baseline video inclusion, before introducing real-life&#xD;
      video debriefings of team performance; 2) During the start-up of the debriefings in an&#xD;
      exploratory study; 3) After real-life video debriefings have been introduced as standard&#xD;
      procedure.&#xD;
&#xD;
      Perspectives:&#xD;
&#xD;
      This project is the first to evaluate the implementation, feasibility and use of real-life&#xD;
      video debriefing in obstetric care. Results from this project can revolutionize the ability&#xD;
      to learn from clinical cases and can guide how video can be introduced in ways acceptable to&#xD;
      women, relatives and healthcare providers.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 11, 2020</start_date>
  <completion_date type="Anticipated">March 2024</completion_date>
  <primary_completion_date type="Anticipated">September 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Data - videos of team performance - will be included as follows:&#xD;
Year 1) Baseline. Video inclusion, before introducing real-life video debriefings of team performance (n=100).&#xD;
Year 2) During the start-up of the debriefings (n=20) which will be evaluated in a feasibility study.&#xD;
Year 2-3) Intervention. After real-life video debriefings have been introduced as standard procedure (n=100).</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Videos from baseline period and intervention period will be mixed and assessed at the end of the study. The raters will be blinded to which period the video originates from</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical performance</measure>
    <time_frame>All videos will be assessed 2.5 years (autumn 2023)</time_frame>
    <description>Videos will be assessed by raters using the TeamOBS-PPH checklist (Brogaard L et al, Development of the TeamOBS-PPH - targeting clinical performance in postpartum hemorrhage, 2018)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Non-technical performance</measure>
    <time_frame>All videos will be assessed 2.5 years (autumn 2023)</time_frame>
    <description>Videos will be assessed by raters using the AOTP checklist.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal birth characteristics. Time of day.</measure>
    <time_frame>Data will be assessed 2.5 years (autumn 2023)</time_frame>
    <description>- Day/Night</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal birth characteristics. Blood loss.</measure>
    <time_frame>Data will be assessed 2.5 years (autumn 2023)</time_frame>
    <description>- Total blood loss (ml)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal birth characteristics. GA.</measure>
    <time_frame>Data will be assessed 2.5 years (autumn 2023)</time_frame>
    <description>- Gestational age</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal birth characteristics. Birth length (&gt;18 hours).</measure>
    <time_frame>Data will be assessed 2.5 years (autumn 2023)</time_frame>
    <description>- Yes/No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal birth characteristics. Epidural</measure>
    <time_frame>Data will be assessed 2.5 years (autumn 2023)</time_frame>
    <description>- Yes/No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal birth characteristics. Oxytocin.</measure>
    <time_frame>Data will be assessed 2.5 years (autumn 2023)</time_frame>
    <description>- Yes/No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal birth characteristics. Induction.</measure>
    <time_frame>Data will be assessed 2.5 years (autumn 2023)</time_frame>
    <description>- Yes/No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal birth characteristics. Twin pregnancy.</measure>
    <time_frame>Data will be assessed 2.5 years (autumn 2023)</time_frame>
    <description>- Yes/No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal characteristics additional. Age.</measure>
    <time_frame>Data will be assessed 2.5 years (autumn 2023)</time_frame>
    <description>- Years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal characteristics additional. BMI.</measure>
    <time_frame>Data will be assessed 2.5 years (autumn 2023)</time_frame>
    <description>- BMI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal characteristics additional. Previous postpartum hemorrhage.</measure>
    <time_frame>Data will be assessed 2.5 years (autumn 2023)</time_frame>
    <description>- Yes/No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal characteristics additional. Previous births</measure>
    <time_frame>Data will be assessed 2.5 years (autumn 2023)</time_frame>
    <description>- Number</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Team characteristics. Team size.</measure>
    <time_frame>Data will be assessed 2.5 years (autumn 2023)</time_frame>
    <description>- Number of team members involved</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Team characteristics. Hospital.</measure>
    <time_frame>Data will be assessed 2.5 years (autumn 2023)</time_frame>
    <description>- Regional / University</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal characteristics. Mean birth weight.</measure>
    <time_frame>Data will be assessed 2.5 years (autumn 2023)</time_frame>
    <description>- Grams</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implementation of video debriefing</measure>
    <time_frame>Data will be assessed 2.5 years (autumn 2023)</time_frame>
    <description>Number of debriefing sessions performed (in total / per participant / failed attempted sessions).</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Postpartum Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Intervention - Video debriefing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Baseline period (year 1): Standard practice. Intervention period (year 2-3): All teams will be assigned to video debriefing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Video debriefing</intervention_name>
    <description>Obstetric teams will review their own performance on video in a debriefing session to improve future performance.</description>
    <arm_group_label>Intervention - Video debriefing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women with major postpartum hemorrhage (1.0 liter or more).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Language difficulties requiring an interpreter or translator&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lena H Rosvig, MD</last_name>
    <phone>+45 25399456</phone>
    <email>lenahede@rm.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lise R Brogaard, MD PhD</last_name>
    <phone>+45 61308100</phone>
    <email>lbrj@clin.au.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus N</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lena H Rosvig, MD</last_name>
      <phone>+45 25399456</phone>
      <email>lenahede@rm.dk</email>
    </contact>
    <contact_backup>
      <last_name>Lise R Brogaard, MD PhD</last_name>
      <phone>+45 61308100</phone>
      <email>lrbj@clin.au.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Lena H Rosvig, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Niels Uldbjerg, MD PhD Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lone Hvidman, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lise R Brogaard, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ole Kierkegaard, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stina Lou, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tanja Manser, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Louis Halamek, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Horsens Regional Hospital</name>
      <address>
        <city>Horsens</city>
        <zip>8700</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lena H Rosvig, MD</last_name>
      <phone>+45 25399456</phone>
      <email>lenahede@rm.dk</email>
    </contact>
    <contact_backup>
      <last_name>Lise R Brogaard, MD PhD</last_name>
      <phone>+45 61308100</phone>
      <email>lrbj@clin.au.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Lena H Rosvig, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Niels Uldbjerg, MD PhD Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lone Hvidman, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lise R Brogaard, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ole Kierkegaard, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stina Lou, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tanja Manser, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Louis Halamek, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <results_reference>
    <citation>Brogaard L, Kierkegaard O, Hvidman L, Jensen KR, Musaeus P, Uldbjerg N, Manser T. The importance of non-technical performance for teams managing postpartum haemorrhage: video review of 99 obstetric teams. BJOG. 2019 Jul;126(8):1015-1023. doi: 10.1111/1471-0528.15655. Epub 2019 Mar 27. Review.</citation>
    <PMID>30771263</PMID>
  </results_reference>
  <results_reference>
    <citation>Brogaard L, Hvidman L, Hinshaw K, Kierkegaard O, Manser T, Musaeus P, Arafeh J, Daniels KI, Judy AE, Uldbjerg N. Development of the TeamOBS-PPH - targeting clinical performance in postpartum hemorrhage. Acta Obstet Gynecol Scand. 2018 Jun;97(6):677-687. doi: 10.1111/aogs.13336. Epub 2018 Apr 2.</citation>
    <PMID>29485679</PMID>
  </results_reference>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 12, 2020</study_first_submitted>
  <study_first_submitted_qc>November 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 30, 2020</study_first_posted>
  <last_update_submitted>January 21, 2021</last_update_submitted>
  <last_update_submitted_qc>January 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postpartum Hemorrhage</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The final dataset will be publicly available in an anonymized form using an open data repository.</ipd_description>
    <ipd_time_frame>Study protocol is available at the projects homepage www.teamobs.dk.&#xD;
Trial related documents and data will be available when results are published and until three years after publication of the last study results.</ipd_time_frame>
    <ipd_access_criteria>Interested parties will be able to request the data by contacting the trial sponsor.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

